33 Infos zu Frank Kruesmann

1 Aktuelle Nachrichten

3 Profile in Sozialen Netzwerken

Frank Kruesmanns berufliches Profil anzeigen LinkedIn ist das weltweit größte berufliche Netzwerk, das Fach- und Führungskräften wie Frank Kruesmann dabei ...

Germany - ‎Bayer HealthCare#####View Frank Kruesmann's profile on LinkedIn, the world's largest professional community. Frank has 1 job listed on their profile. See the complete profile on ...

Semantic Scholar profile for Frank Kruesmann, with 1 highly influential citations and 8 scientific research papers.

2 Bücher zum Namen

Moxifloxacin Safety | Professor Paul M. Tulkens, Pierre Arvis, Frank Kruesmann | download | BookSC. Download books for free. Find books

1 Dokumente

Frank Kruesmann. Find this author on Google Scholar · Find this author on PubMed · Search for this author on this site. Daniel Haverstock.

6 Allgemeine Veröffentlichungen

Frank Kruesmann

Volume 12, issue 2 articles listing for Drugs in R&D

Communication Consultancy, funded by Bayer Pharma AG. CONFLICT OF INTEREST. Frank Kruesmann, Anna Fritsch, David van Veenhuyzen and Pierre Arvis ...

Renee Perroncel

19 Webfunde aus dem Netz

View Frank Kruesmann's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Frank Kruesmann discover ...

Frank Kruesmann's 7 research works with 170 citations and 1,119 reads, including: Efficacy and Safety of Moxifloxacin in Hospitalized Patients with Secondary Peritonitis: Pooled Analysis of Four...

Search results for: Frank Kruesmann ... Paul M. Tulkens, Pierre Arvis, Frank Kruesmann · Drugs in R&D > > 12 > 2 >

includes Comparative efficacy of oral and sequential intravenous by Antonio Anzueto, Daniel Haverstock, Fra. Click to explore.

Current Drug Safety publishes frontier articles on all the latest advances on drug safety. The journal aims to publish the highest quality research...

Antonio Anzueto MD* Daniel Haverstock MS Frank Kruesmann PhD Shurjeel Choudhri MD Univ. of Texas Health Sci. Ctr., San Antonio, TX. PURPOSE: To ...

Paul M Tulkens, Pierre Arvis, Frank Kruesmann Drugs in R&D June 1, 12 (2): Safety of growth hormone treatment in pediatric patients with ...

An Analysis of 14 Years of Clinical Data. Paul M. Tulkens, Pierre Arvis, Frank Kruesmann · Details · Contributors · Fields of science · Bibliography · Quotations ...

... Kiliana Suzart-Woischnik, Frank Kruesmann, Pierre Arvis, N Franklin Adkinson, Jr, Werner J Pichler, Gillian M Shepherd, John D Seeger Clinical Outcomes ...

Paul M Tulkens, Pierre Arvis, Frank Kruesmann (2012) Moxifloxacin safety: an analysis of 14 years of clinical data. Drugs in R&D 12: Jun.

Pierre Arvis and Frank Kruesmann are employees of Bayer Santé SAS and Bayer Pharma AG, respectively. this website References 1.

Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis. Marc Miravitlles, Frank Kruesmann, +3 authors Pierre Arvis; Published

Cardiac safety was compared in patients receiving moxifloxacin and other antimicrobials in a large patient population from Phase II–IV randomized active

Aug 26, a Systematic Review of In Vitro, Animal and Prescribing: Results from a Post-Marketing. Study [138]...

... Jeffrey D. Alder, PhD, Global Clinical Development, Bayer HealthCare, Montville, NJ, Frank Kruesmann, Bayer Pharma AG, Wuppertal, Germany, Pierre Arvis, ...